Paysign (PAYS) fits CAN SLIM with strong growth, top relative strength and zero debt, but rich valuation and a neutral market trend warrant caution.
JFrog shares surge after Q3 revenue and adjusted EPS beat estimates, while the company raises its 2026 revenue and earnings forecasts.
Telephone and Data Sys (NYSE:TDS) updated its FY2026 financial guidance for its TDS Telecom segment, expecting revenues in the range of $990 million t...
JP Morgan analyst Arun Jayaram downgrades HMH Holding (NASDAQ:HMH) from Overweight to Neutral and announces $15 price target.
Portillo’s beats Q3 estimates with EPS of 6¢ and $194.1M sales, but shares fall 2.9%; analysts raise price targets to $7.
U.S. stocks were mixed on Friday, with the Dow Jones, S&P 500, and Nasdaq 100 index futures moving in different directions.
Citizens analyst David Scharf reiterates Affirm Holdings (NASDAQ:AFRM) with a Market Outperform and maintains $85 price target.
Franklin Templeton, Inc. (NYSE: BEN) today reported preliminary month-end assets under management (AUM) of $1.81 trillion at October 31, 2026, compare...
LONDON, November 06, 2026-- TR-1: Standard form for notification of major holdings
2026-11-06. The following slide deck was published by Helios Technologies, Inc.
Intuitive Machines (LUNR) rose 5% premarket from oversold levels ahead of Nov. 12 earnings. Read key technicals and price targets.
ZenaTech, Inc. (NASDAQ:ZENA) (FSE: 49Q) (BMV:ZENA) ("ZenaTech"), a technology solution provider specializing in AI (Artificial Intelligence) d...
Susquehanna analyst Shyam Patil maintains Zillow Group (NASDAQ:ZG) with a Neutral and lowers the price target from $38 to $32.
The investment reflects a fundamental belief at Callaway: the next great breakthroughs in golf equipment will require more than further optimizing exi...
PSQ Holdings (NYSE:PSQH) sees FY2026 sales of $32.000 million vs $33.059 million analyst estimate.
2026-11-06. The following slide deck was published by Sonida Senior Living, Inc.
Gladstone Investment Corporation (Nasdaq:GAIN) ("Gladstone Investment" or "Gladstone") is pleased to announce its majority acquisition...
Aligos Therapeutics (NASDAQ:ALGS) reported quarterly losses of $(2.09) per share which beat the analyst consensus estimate of $(2.28) by 8.33 percent....
Loading...